The Canadian Journal of Microbiology, published by Canadian Science Publishing, is a well-respected journal established in 1954 that serves as a vital platform for advancing knowledge in the fields of microbiology and related disciplines. With an ISSN of 0008-4166 and an E-ISSN of 1480-3275, this journal is recognized for its rigorous peer-review process and its commitment to disseminating high-quality research that spans applied microbiology, biotechnology, genetics, immunology, and more. Currently indexed in several prestigious databases, its impact factor and category quartiles highlight its significance, ranking in the top tiers of applied microbiology and biotechnology as well as other intersecting fields. The journal provides an essential resource for researchers, professionals, and students seeking to stay informed on the latest advancements and breakthroughs, facilitating collaboration and innovation in the microbiological sciences. Set in the dynamic landscape of academia from its headquarters in Ottawa, Canada, the Canadian Journal of Microbiology remains steadfast in its mission to promote research that addresses key challenges and opportunities within the microbiological community.

FOLIA MICROBIOLOGICA is a distinguished academic journal published by SPRINGER, focusing on the intricate realms of microbiology and its contributions to medicine. Since its inception in 1957, the journal has been a vital platform for disseminating pioneering research, addressing contemporary challenges in the field while facilitating discourse among researchers, clinicians, and students alike. With an ISSN of 0015-5632 and an E-ISSN of 1874-9356, FOLIA MICROBIOLOGICA publishes original articles, reviews, and critical insights that span not only traditional microbiological studies but also innovative applications in immunology and biotechnology. The journal is categorized within the esteemed Q2 tier in Medicine (Miscellaneous) and holds a Q3 rating in Microbiology as of 2023, reflecting its significant impact and relevance in the scientific community. Although it does not currently offer open access, it remains a respected resource, enabling professionals and students to keep abreast of advancements from its base in the Netherlands. With a strong commitment to quality and rigorous peer-review, FOLIA MICROBIOLOGICA serves as an essential repository of knowledge, fostering the next generation of microbiologists and medical practitioners.

Synthetic and Systems Biotechnology, published by KEAI PUBLISHING LTD, is a pioneering open-access journal that has made significant contributions to the fields of applied microbiology, biotechnology, biomedical engineering, genetics, and structural biology since its inception in 2016. With an ISSN of 2405-805X, this journal is committed to fostering innovative research and interdisciplinary collaboration, providing a platform for the dissemination of high-quality studies that push the boundaries of scientific knowledge. Recognized for its excellence, it holds prestigious Q1 rankings in both Applied Microbiology and Biotechnology as well as Biomedical Engineering in 2023, alongside notable Q2 rankings in Genetics and Structural Biology. Researchers, professionals, and students alike can access cutting-edge research that explores the dynamic interplay between synthetic biology and systems biology, driving advancements that could reshape health, industry, and environmental sustainability. By operating under an open-access model, Synthetic and Systems Biotechnology ensures that new findings are accessible to a global audience, thereby maximizing the impact and reach of the published work and paving the way for future discoveries.

AIMS Microbiology, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed Open Access journal dedicated to advancing the field of microbiology since its inception in 2015. With an ISSN of 2471-1888, the journal aims to disseminate high-quality research and innovative findings pertaining to both fundamental and applied microbiology, encompassing areas such as medical microbiology, immunology, and related life sciences. Recognized for its academic rigor, AIMS Microbiology has achieved a significant standing, evidenced by its current Q2 ranking in both Microbiology and Medical Microbiology categories, along with impressive percentile rankings within prestigious Scopus metrics. Based in the United States, the journal not only emphasizes accessibility and widespread dissemination of knowledge but also plays a crucial role in fostering collaboration among researchers and professionals in the microbiological sciences. By providing a platform for collaborative research and innovative ideas, AIMS Microbiology is poised to influence the future development and application of microbiological research, making it a valuable resource for students, researchers, and practitioners alike.

Microorganisms is a leading open-access journal published by MDPI based in Switzerland, catering specifically to the rapidly evolving fields of microbiology and virology. Since its inception in 2013, the journal aims to foster the dissemination of high-quality research through its comprehensive and interdisciplinary platform, with a particular focus on both fundamental and applied microbiological sciences. Contributing to its esteemed reputation, Microorganisms holds a commendable Q2 ranking in the categories of Microbiology and Virology, as well as in Medical Microbiology, highlighting its significance in the academic community. With a consistent impact, evidenced by its rankings in Scopus—such as rank #25 in Virology and #56 in Microbiology—the journal serves as an invaluable resource for researchers, professionals, and students looking to stay at the forefront of microbiological research. As an open-access journal, Microorganisms ensures that vital research findings are readily available to a global audience, promoting collaboration and innovation in the study of microbial life and its implications for health and disease.

BIOTECHNOLOGY ADVANCES is a premier, peer-reviewed journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing knowledge in the rapidly evolving fields of biotechnology and bioengineering. With an ISSN of 0734-9750 and an E-ISSN of 1873-1899, this esteemed journal covers a wide spectrum of topics relevant to applied microbiology, molecular biology, and biochemical innovation. Recognized for its academic rigor, it holds a distinguished position in the top quartile (Q1) in multiple categories, including Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology, further evidenced by its high rankings in Scopus, where it ranks #3/127 in Applied Microbiology and Biotechnology and #7/311 in Biotechnology. Researchers and professionals in the field value the journal not only for its comprehensive coverage of cutting-edge research but also for its commitment to disseminating critical findings and fostering collaboration. While BIOTECHNOLOGY ADVANCES currently operates under a subscription model, its potential impact on future innovations in biotechnology cannot be overstated, making it an essential resource for anyone interested in the forefront of biotechnological advancements.

BIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.

Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.

WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, published by Springer, serves as a pivotal forum for advancing the fields of microbiology and biotechnology since its inception in 1990. Located in the Netherlands, this esteemed journal has secured a prominent position in the academic landscape, recognized for its strong impact factor and prestigious Q2 category rankings across disciplines such as Applied Microbiology, Biotechnology, and Physiological Sciences. Researchers and professionals utilize this journal to disseminate innovative findings and explore emerging technologies that are transforming the scientific landscape. With a robust submission rate and high visibility among the academic community, the journal fosters interdisciplinary collaboration, encouraging discussions that bridge gaps between theory and practical applications. As it converges into 2024, the WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY continues to be a vital resource for scholars aiming to enhance our understanding of microbial processes and biotechnological advances.

CRITICAL REVIEWS IN BIOTECHNOLOGY, published by Taylor & Francis Ltd, stands as a leading journal in the field of biotechnology, consistently recognized for its rigorous peer-reviewed articles that impact the disciplines of Applied Microbiology, Biotechnology, and Medicine. With an impressive Q1 ranking in these categories and a significant influence reflected in its Scopus rankings—placing it within the top 5% of Applied Microbiology and the top 4% of Biotechnology journals—the journal serves as an essential resource for researchers, professionals, and students alike. Launched in 1983 and extending its coverage to encompass groundbreaking findings through 2024, it provides a rich forum for insightful reviews and innovative research that propel the field forward. Though not an Open Access journal, CRITICAL REVIEWS IN BIOTECHNOLOGY remains a vital point of reference for ongoing developments, critical analyses, and emerging trends, making it indispensable for those seeking to stay at the forefront of biotechnological advancements.